| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5650442 | The American Journal of Emergency Medicine | 2017 | 5 Pages |
Abstract
Clevidipine administration during initial medical management of aortic dissection showed similar efficacy compared to SNP when used as adjunct therapy to esmolol. These data suggest clevidipine is a less costly, reasonable alternative to SNP in acute aortic dissection as adjunct therapy to esmolol. Further studies are needed to validate these results.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
Authors
Alexandru PharmD, Jon PharmD, Timothy S. PharmD, Shannon PharmD, MPH, Domenico MD, PhD, Jon B. MD,